Suppr超能文献

乙醇与饮食性肝病中细菌易位和肝损伤的差异。

Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease.

机构信息

Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, MC0063, USA.

Department of Medicine, VA San Diego Healthcare System, San Diego, CA, USA.

出版信息

Dig Dis Sci. 2023 Jul;68(7):3059-3069. doi: 10.1007/s10620-023-07860-1. Epub 2023 Feb 20.

Abstract

BACKGROUND

Alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) are two of the most common etiologies of chronic liver disease worldwide. Changes in intestinal permeability and increased gut microbial translocation have been posited as important contributors to inflammation in both ALD and NAFLD. However, gut microbial translocation has not been compared between the two etiologies and can lead to better understanding of the differences in their pathogenesis to liver disease.

METHODS

We compared serum and liver markers in the following five models of liver disease to understand the differences in the role of gut microbial translocation on liver disease progression caused by ethanol versus Western diet: (1) 8-week chronic ethanol feeding model. (2) 2-week chronic-plus-binge (National Institute on Alcohol Abuse and Alcoholism (NIAAA)) ethanol feeding model. (3) 2-week chronic-plus-binge (NIAAA) ethanol feeding model in microbiota-humanized gnotobiotic mice colonized with stool from patients with alcohol-associated hepatitis. (4) 20-week Western-diet-feeding model of NASH. (5) 20-week Western-diet-feeding model in microbiota-humanized gnotobiotic mice colonized with stool from NASH patients.

RESULTS

Translocation of bacterial lipopolysaccharide to the peripheral circulation was seen in both ethanol-induced and diet-induced liver disease, but translocation of bacteria itself was restricted to only ethanol-induced liver disease. Moreover, the diet-induced steatohepatitis models developed more significant liver injury, inflammation, and fibrosis compared with ethanol-induced liver disease models, and this positively correlated with the level of lipopolysaccharide translocation.

CONCLUSIONS

More significant liver injury, inflammation, and fibrosis are seen in diet-induced steatohepatitis, which positively correlates with translocation of bacterial components, but not intact bacteria.

摘要

背景

酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)是全球最常见的慢性肝病病因学之一。肠通透性改变和肠道微生物易位增加被认为是ALD 和 NAFLD 炎症的重要原因。然而,尚未比较这两种病因学之间的肠道微生物易位,这可以更好地理解它们导致肝病的发病机制的差异。

方法

我们比较了以下五种肝病模型中的血清和肝脏标志物,以了解乙醇与西方饮食导致肝病进展过程中肠道微生物易位的作用差异:(1)8 周慢性乙醇喂养模型。(2)2 周慢性加 binge(国家酒精滥用和酒精中毒研究所(NIAAA))乙醇喂养模型。(3)2 周慢性加 binge(NIAAA)乙醇喂养模型,在定植有酒精性肝炎患者粪便的共生无菌小鼠中。(4)20 周 NASH 西方饮食喂养模型。(5)20 周西方饮食喂养模型,在定植有 NASH 患者粪便的共生无菌小鼠中。

结果

细菌脂多糖向外周循环的易位在乙醇诱导和饮食诱导的肝病中均可见,但细菌本身的易位仅限于乙醇诱导的肝病。此外,与乙醇诱导的肝病模型相比,饮食诱导的脂肪性肝炎模型发展出更显著的肝损伤、炎症和纤维化,并且这与脂多糖易位水平呈正相关。

结论

在饮食诱导的脂肪性肝炎中观察到更显著的肝损伤、炎症和纤维化,这与细菌成分的易位呈正相关,而不是完整细菌的易位。

相似文献

1
Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease.
Dig Dis Sci. 2023 Jul;68(7):3059-3069. doi: 10.1007/s10620-023-07860-1. Epub 2023 Feb 20.
2
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7.
3
Mouse Model of Alcoholic Steatohepatitis.
Methods Mol Biol. 2020;2164:145-157. doi: 10.1007/978-1-0716-0704-6_15.
4
The fecal mycobiome in non-alcoholic fatty liver disease.
J Hepatol. 2022 Apr;76(4):788-799. doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 10.
5
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
J Hepatol. 2019 Dec;71(6):1216-1228. doi: 10.1016/j.jhep.2019.08.005. Epub 2019 Aug 13.
6
Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and prevents ethanol-induced liver disease in mice.
Gut. 2023 Oct;72(10):1959-1970. doi: 10.1136/gutjnl-2022-328265. Epub 2023 Jan 23.
7
Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice.
Alcohol Clin Exp Res. 2016 Dec;40(12):2604-2613. doi: 10.1111/acer.13239. Epub 2016 Oct 14.
8
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
Gastroenterology. 2015 Jan;148(1):203-214.e16. doi: 10.1053/j.gastro.2014.09.014. Epub 2014 Sep 16.
9
Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis.
Acta Physiol (Oxf). 2022 Jul;235(3):e13827. doi: 10.1111/apha.13827. Epub 2022 May 10.
10
Alcoholic liver disease: the gut microbiome and liver cross talk.
Alcohol Clin Exp Res. 2015 May;39(5):763-75. doi: 10.1111/acer.12704.

引用本文的文献

1
mAChR4 suppresses liver disease via GAP-induced antimicrobial immunity.
Nature. 2025 Aug 20. doi: 10.1038/s41586-025-09395-z.
2
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases.
Microorganisms. 2025 May 23;13(6):1188. doi: 10.3390/microorganisms13061188.
3
Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease.
J Clin Invest. 2025 May 13;135(13). doi: 10.1172/JCI188541. eCollection 2025 Jul 1.
4
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2.
5
Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders.
World J Gastroenterol. 2025 Jan 28;31(4):101436. doi: 10.3748/wjg.v31.i4.101436.
7
Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer.
Am J Prev Cardiol. 2024 Oct 28;20:100888. doi: 10.1016/j.ajpc.2024.100888. eCollection 2024 Dec.
9
Gut Bacteria in Alcohol-Associated Liver Disease.
Clin Liver Dis. 2024 Nov;28(4):663-679. doi: 10.1016/j.cld.2024.06.008. Epub 2024 Jul 24.
10
Gut mycobiome alterations and implications for liver diseases.
PLoS Pathog. 2024 Aug 8;20(8):e1012377. doi: 10.1371/journal.ppat.1012377. eCollection 2024 Aug.

本文引用的文献

2
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
J Hepatol. 2022 Oct;77(4):918-930. doi: 10.1016/j.jhep.2022.04.040. Epub 2022 May 20.
3
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?
Hepatology. 2022 Nov;76(5):1423-1437. doi: 10.1002/hep.32499. Epub 2022 May 2.
4
Intrahepatic microbes govern liver immunity by programming NKT cells.
J Clin Invest. 2022 Apr 15;132(8). doi: 10.1172/JCI151725.
5
The fecal mycobiome in non-alcoholic fatty liver disease.
J Hepatol. 2022 Apr;76(4):788-799. doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 10.
6
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease.
Nat Commun. 2021 Dec 9;12(1):7172. doi: 10.1038/s41467-021-27385-3.
7
The microbiota in cirrhosis and its role in hepatic decompensation.
J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S67-S81. doi: 10.1016/j.jhep.2020.11.013.
8
Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice.
Cell Mol Gastroenterol Hepatol. 2021;12(1):293-320. doi: 10.1016/j.jcmgh.2021.02.009. Epub 2021 Feb 22.
9
Epidemiology of non-alcoholic and alcoholic fatty liver diseases.
Transl Gastroenterol Hepatol. 2020 Apr 5;5:16. doi: 10.21037/tgh.2019.09.08. eCollection 2020.
10
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.
Nature. 2019 Nov;575(7783):505-511. doi: 10.1038/s41586-019-1742-x. Epub 2019 Nov 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验